Randomized phase II study of adding steroid for prevention of venous pain in colorectal cancer patients who are receiving oxaliplatin through peripheral vein (APOLLO)
Ontology highlight
ABSTRACT: Interventions: XELOX Oxaliplatin 130mg/m2 day1 Capecitabine 2,000mg/m2 day1-14 every 3 weeks SOX Oxaliplatin 130mg/m2 day1 S-1 80-120mg/m2 day1-14 every 3 weeks Oxaliplatin is combined with dexamethasone (2 mg).
XELOX Oxaliplatin 130mg/m2 day1 Capecitabine 2,000mg/m2 day1-14 every 3 weeks SOX Oxaliplatin 130mg/m2 day1 S-1 80-120mg/m2 day1-14 every 3 weeks
Primary outcome(s): The incidence of venous pain:Grade>=2
Study Design: Parallel Randomized
DISEASE(S): Colorectal Cancer
PROVIDER: 2619736 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA